INTERNATIONAL HEADACHE SOCIETY

Registered charity 1042574 · accounts filings on the Charity Commission register · also known as IHS

Publication of peer-reviewed journal-Cephalalgia; Educational materials; Development and publication of international headache guidelines and classification; Education of neurologists and other HCPs in underserved countries/regions; Scientific research grants; Website; Bi-ennial international congress; Support for young physicians attending international headache congresses and headache centres

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts

Latest income

£705k

Latest spending

£658k

Registered

1994

Accounts read

FY2024

Financial health, per its FY2024 accounts

The accounts state that the group reported a net increase in funds of £202,008 for the year ended 31 December 2024, with total unrestricted reserves standing at £3,135,397. The Trustees consider the current level of reserves to be high, noting that the policy target is a general reserve in the region of two to three times expected annual expenditure (£1.5m to £2.3m). The group continues to adopt the going concern basis, citing adequate resources for the foreseeable future.

Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: Membership fees (20% of income)

“membership fees reached £137,336” — page 14

Per its FY2024 accounts as filed with the Charity Commission.

Reserves policy: two to three times the expected annual expenditure (£1.5m to £2.3m) (held: £3.1m)

“the Trustees consider it appropriate to maintain a general reserve in the region of two to three times the expected annual expenditure (£1.5m to £2.3m)”

Per its FY2024 accounts as filed with the Charity Commission.

Trading subsidiary: IHS Trading Company

“IHS (via the IHS Trading Company) hosts the biennial International Headache Congress (IHC)” — page 8

Per its FY2024 accounts as filed with the Charity Commission.

Accounts audited by MHA. Discloses 5 of 6 completeness components.

Funders the charity credits

Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).

Abbvie — “IHS thanks its industry Roundtable Corporate Members for their support Abbvie” (source page)

Public profiles (found on the charity’s own website): facebook · instagram

Structured financials (annual return, FY ending 31/12/2024)

Total income

£705k

Total spending

£658k

Cost of raising funds

£244k

Reserves (reported)

£3.1m

Employees

Reported reserves equal ~57.1 months of spending — in the top quarter for charities its size (median 5.2 months; benchmarks).

Per its annual return, largest income source: Charitable activities (67% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 34.6% of total income — above the 90th percentile for charities its size (median 4.9%) (benchmarks).

Trustees · trustee networks

Dr Anna Antreou
Dr Derya Uluduz
Dr Freda Dodd-Glover
Dr Hsiangkuo Yuan
Dr Irma Savitri Madjid
Dr Joe Fernando Munoz-Ceron
Dr Marcelo Moraes Valenca
Dr Mario Fernando Prieto Peres
Dr Morris Levin
Dr Patricia Pozo-Rosich
Dr Piero Barbanti
Dr Rami Burstein
Dr Sait Ashina
Eduardo Bundyra
Professor FAYYAZ AHMED · trustee of 1 other charity

Trustee list from the Charity Commission register (current, not historical).

Operates in: Argentina · Armenia · Australia · Austria · Belgium · Brazil · Bulgaria · Burma · Cameroon · Canada · China · Colombia

Income and spending

Financial year end	Income	Spending
31/12/2024	£705k	£658k
31/12/2023	£895k	£923k
31/12/2022	£1.0m	£853k
31/12/2021	£1.2m	£688k
31/12/2020	£666k	£709k

Common questions

Is INTERNATIONAL HEADACHE SOCIETY financially healthy?

Per its FY2024 accounts: The accounts state that the group reported a net increase in funds of £202,008 for the year ended 31 December 2024, with total unrestricted reserves standing at £3,135,397. The Trustees consider the current level of reserves to be high, noting that the policy target is a general reserve in the region of two to three times expected annual expenditure (£1.5m to £2.3m). The group continues to adopt the going concern basis, citing adequate resources for the foreseeable future. Its FY2024 accounts were audited by MHA.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Funder	Similar charities funded	Amount to them
ROBERT LUFF FOUNDATION LIMITED	3	£147k
CECIL PILKINGTON CHARITABLE TRUST	3	£32k
THE INMAN CHARITY	3	£18k
G M MORRISON CHARITABLE TRUST	2	£12k
MISSES BARRIE CHARITABLE TRUST	2	£11k
THE OAKDALE TRUST	2	£7k
GOWLING WLG (UK) CHARITABLE TRUST	2	£4k
THE SIR JAMES ROLL CHARITABLE TRUST	2	£3k

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with NATIONAL MIGRAINE CENTRE.

NATIONAL MIGRAINE CENTRE income £826k
Encephalitis International income £1.3m
THE MIGRAINE TRUST income £1.0m
THE GET A HEAD CHARITABLE TRUST income £351k
ASTRO BRAIN TUMOUR FUND income £177k
BRITISH PAEDIATRIC NEUROLOGY ASSOCIATION income £1.3m

Side by side with its peers

Charity	Income	Top pay band	Staff >£60k	Reserves vs policy	Fundraising cost	Going concern
INTERNATIONAL HEADACHE SOCIETY	£705k	—	0	unclear	—	no doubt
NATIONAL MIGRAINE CENTRE FY2025	£826k	in excess of £80,000	1	above	—	no doubt
Encephalitis International FY2025	£1.3m	—	—	unclear	—	no doubt
THE MIGRAINE TRUST FY2025	£1.0m	—	—	unclear	—	no doubt
THE GET A HEAD CHARITABLE TRUST FY2024	£351k	—	0	unclear	—	no doubt
ASTRO BRAIN TUMOUR FUND FY2026	£177k	—	0	unclear	—	no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.